Oragenics gets common stock listing on NYSE

Oragenics has had its common stock approved for listing on the NYSE Euronext's NYSE MKT.

Trading is expected to commence on the NYSE MKT on April 10, 2013, under the ticker symbol OGEN.

The listing approval is contingent on the company continuing to meet all of the initial listing requirements on the day it is scheduled to commence trading.

Page 1 of 207
Next Page